SOLID ADVANCED TUMOR
Clinical trials for SOLID ADVANCED TUMOR explained in plain language.
Never miss a new study
Get alerted when new SOLID ADVANCED TUMOR trials appear
Sign up with your email to follow new studies for SOLID ADVANCED TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests two drugs, MCLA-129 and ensartinib, together in people with advanced solid tumors that cannot be cured by standard treatments. The goal is to see if the combination is safe and can shrink or control tumors. About 164 adults aged 18-75 with certain cancers like lu…
Matched conditions: SOLID ADVANCED TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Betta Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 06:00 UTC
-
New antibody OSE-279 aims to unleash immune system against tumors
Disease control Recruiting nowThis study tests a new drug called OSE-279 that helps the immune system fight cancer by blocking a protein called PD-1. It is for people with advanced solid tumors or lymphomas that have not responded to other treatments. The trial has three parts: first finding the safest dose, …
Matched conditions: SOLID ADVANCED TUMOR
Phase: PHASE1, PHASE2 • Sponsor: OSE Immunotherapeutics • Aim: Disease control
Last updated May 26, 2026 05:49 UTC